153 related articles for article (PubMed ID: 19000371)
1. Regulation of CMV promoter-driven exogenous gene expression with doxorubicin in genetically modified cells.
Kinoshita A; Kobayashi D; Hibino Y; Isago T; Uchino K; Yagi K; Hirai M; Saitoh Y; Komada F
J Pharm Pharmacol; 2008 Dec; 60(12):1659-65. PubMed ID: 19000371
[TBL] [Abstract][Full Text] [Related]
2. Effects of anticancer agents and scavengers on CMV-promoter-driven exogenous gene expression in genetically modified cells.
Kinoshita A; Kobayashi D; Saitoh Y; Komada F
J Pharm Pharmacol; 2009 Apr; 61(4):527-31. PubMed ID: 19298701
[TBL] [Abstract][Full Text] [Related]
3. Regulation of exogenous gene expression by superoxide.
Kinoshita A; Kobayashi D; Saitoh Y; Tanabe N; Uchino K; Nishiguchi K; Okumura K; Komada F
Pharm Res; 2006 Nov; 23(11):2536-41. PubMed ID: 17048122
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells.
Kim KI; Kang JH; Chung JK; Lee YJ; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2007 Sep; 48(9):1553-61. PubMed ID: 17704247
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific expression detected with the use of an expression vector driven by human telomerase reverse transcriptase gene promoter.
Yin J; Fu P; Wang X; Jin G; Xiu R
J Lab Clin Med; 2004 Dec; 144(6):302-6. PubMed ID: 15614252
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy.
Svensson RU; Barnes JM; Rokhlin OW; Cohen MB; Henry MD
Cancer Res; 2007 Nov; 67(21):10445-54. PubMed ID: 17974988
[TBL] [Abstract][Full Text] [Related]
7. [Nanoparticle-mediated endostatin gene therapy targeting hepatocellular carcinoma utilizing heat-inducible promoter].
Zhou JJ; Chen RF; Li ZH; Zhou QB; Tang QB; He XY; Lu HW; Guo N
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):795-9. PubMed ID: 19595115
[TBL] [Abstract][Full Text] [Related]
8. [Construction and identification of a tumor-specific expression vector driven by human telomerase reserve transcriptase gene promotor].
Yin JJ; Hu X; Fu PF; Yuan XD; Zhang JY
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1274-7. PubMed ID: 12930647
[TBL] [Abstract][Full Text] [Related]
9. Plasmid vectors harboring cellular promoters can induce prolonged gene expression in hematopoietic and mesenchymal progenitor cells.
Byun HM; Suh D; Jeong Y; Wee HS; Kim JM; Kim WK; Ko JJ; Kim JS; Lee YB; Oh YK
Biochem Biophys Res Commun; 2005 Jul; 332(2):518-23. PubMed ID: 15893736
[TBL] [Abstract][Full Text] [Related]
10. [Gene transfection of endostatin synergizes with doxorubicin to suppress human hepatocellular carcinomas: experiment with mice].
Liu FJ; Tan G; Li J; Sun XY
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2147-51. PubMed ID: 19080480
[TBL] [Abstract][Full Text] [Related]
11. [Construction and expression of EGFP controlled HBV promoters in eukaryotic cells].
Xie N; Wang XY; Zhang Q; Lin YY; Lin JS
Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):268-71. PubMed ID: 16635295
[TBL] [Abstract][Full Text] [Related]
12. [Mammalian gene-transfer and expression efficiencies of baculovirus bacV-CMV-EGFPA].
Xu CY; Cheng T; Lu WX; Chen M; Wu T; Wang YB; Zhang J; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):73-7. PubMed ID: 16108494
[TBL] [Abstract][Full Text] [Related]
13. High levels of protein expression using different mammalian CMV promoters in several cell lines.
Xia W; Bringmann P; McClary J; Jones PP; Manzana W; Zhu Y; Wang S; Liu Y; Harvey S; Madlansacay MR; McLean K; Rosser MP; MacRobbie J; Olsen CL; Cobb RR
Protein Expr Purif; 2006 Jan; 45(1):115-24. PubMed ID: 16289982
[TBL] [Abstract][Full Text] [Related]
14. The human cytomegalovirus immediate-early promoter is transcriptionally active in undifferentiated mouse embryonic stem cells.
Ward CM; Stern PL
Stem Cells; 2002; 20(5):472-5. PubMed ID: 12351818
[TBL] [Abstract][Full Text] [Related]
15. A comparison of enhanced green fluorescent protein expression induced by immediate-early cytomegalovirus (IE-CMV) and gG pseudorabies virus (gG-PRV) promoters, using pseudorabies virus amplicons as vectors.
Muñoz AL; Prieto C; Tabarés E
J Virol Methods; 2006 Sep; 136(1-2):257-60. PubMed ID: 16712964
[TBL] [Abstract][Full Text] [Related]
16. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
Willhauck MJ; Sharif Samani BR; Klutz K; Cengic N; Wolf I; Mohr L; Geissler M; Senekowitsch-Schmidtke R; Göke B; Morris JC; Spitzweg C
Gene Ther; 2008 Feb; 15(3):214-23. PubMed ID: 17989705
[TBL] [Abstract][Full Text] [Related]
17. [Expression of the radio-inducible TK suicide gene controlled by Egr-1 promoter in pancreatic cancer cells: an in vitro experiment].
Liu JL; Liu XL; Qian Q; Du Q; Guo SY; Li CJ; Miao Y
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1952-5. PubMed ID: 19062733
[TBL] [Abstract][Full Text] [Related]
18. Activator protein 1-mediated transcriptional regulation strategy sustains long-term expression of a xenogeneic gene product in vivo: an implication for gene therapy targeting congenital protein deficiencies.
Sasaki S; Smith JM; Takase K; Okuda K; Ishii N; Takeshita F
Int J Mol Med; 2006 Aug; 18(2):289-97. PubMed ID: 16820937
[TBL] [Abstract][Full Text] [Related]
19. [Gene therapy targeting for carcinoma regulated by E2F-1 promoter].
Zhang XW; Meng ZH; Zhao JS; Zhang D; Xie YJ; Gao SH; Wang CY
Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1636-9. PubMed ID: 17359698
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of reduced folate carrier gene (RFC1) expression after exposure to methotrexate in ZR-75-1 breast cancer cells.
Ma D; Huang H; Moscow JA
Biochem Biophys Res Commun; 2000 Dec; 279(3):891-7. PubMed ID: 11162445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
